These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6315565)

  • 1. Loss of electron-dense lamellar material from Fabry's disease fibroblasts after enzyme replacement.
    Sifers RN; Mayes JS; Nordquist RE
    Hum Genet; 1983; 65(1):85-7. PubMed ID: 6315565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme replacement in Fabry endothelial cells and fibroblasts: uptake experiments and electron microscopical studies.
    Hasholt L; Wandall A; Sørensen SA
    Clin Genet; 1988 May; 33(5):360-71. PubMed ID: 2837353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast alpha-galactosidase A activity for identification of Fabry's disease heterozygotes.
    Fensom AH; Benson PF; Grant AR; Jacobs L
    J Inherit Metab Dis; 1980; 2(1):9-12. PubMed ID: 6273649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fate of internalized alpha-2-macroglobulin: alpha-galactosidase conjugate in fibroblasts from Fabry's hemizygote.
    Osada T; Kuroda Y; Ikai A
    Biochem Biophys Res Commun; 1987 Mar; 143(3):954-8. PubMed ID: 2436620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease.
    Mayes JS; Scheerer JB; Sifers RN; Donaldson ML
    Clin Chim Acta; 1981 May; 112(2):247-51. PubMed ID: 6263521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Fabry's disease heterozygote with a new mutation: biochemical, ultrastructural, and clinical investigations.
    Hasholt L; Sørensen SA; Wandall A; Andersen EB; Arlien-Søborg P
    J Med Genet; 1990 May; 27(5):303-6. PubMed ID: 2161929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathology of Fabry's disease. Physical and kinetic properties of alpha-galactosidase A in cultured human endothelial cells.
    Johnson DL; Desnick RJ
    Biochim Biophys Acta; 1978 Jan; 538(2):195-204. PubMed ID: 23178
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship of the multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase in the normal and in Fabry's disease.
    Beyer E; Schono N; Kozlova I; Wiederschain G
    Biochim Biophys Acta; 1990 May; 1038(3):386-9. PubMed ID: 2160280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biochemical studies in Fabry's disease (author's transl)].
    Handa S
    Nihon Jinzo Gakkai Shi; 1978 Nov; 20(11):1212-4. PubMed ID: 219278
    [No Abstract]   [Full Text] [Related]  

  • 10. Electron microscopic observations on cultured fibroblasts from Fabry heterozygotes and hemizygotes.
    Wandall A; Hasholt L; Sørensen SA
    Ultrastruct Pathol; 1982; 3(1):51-8. PubMed ID: 6280349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual activity of alpha-galactosidase A in Fabry's disease.
    Romeo G; D'Urso M; Pisacane A; Blum E; De Falco A; Ruffilli A
    Biochem Genet; 1975 Oct; 13(9-10):615-28. PubMed ID: 812485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocytotic internalization of alpha-2-macroglobulin: alpha-galactosidase conjugate by cultured fibroblasts derived from Fabry hemizygote.
    Osada T; Kuroda Y; Ikai A
    Biochem Biophys Res Commun; 1987 Jan; 142(1):100-6. PubMed ID: 2434088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone phenocopy of Fabry's keratopathy.
    Whitley CB; Tsai MY; Heger JJ; Prystowsky EN; Zipes DP
    JAMA; 1983 Apr 22-29; 249(16):2177-8. PubMed ID: 6300478
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of Fabry's disease heterozygotes by enzyme analysis in single fibroblasts after cell sorting.
    Jongkind JF; Verkerk A; Niermeijer MF
    Clin Genet; 1983 Apr; 23(4):261-6. PubMed ID: 6303650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of immobilized fig alpha-galactosidase and effect on ceramide-3 content of plasma from patients with Fabry's disease.
    Schram AW; Hamers MN; Oldenbroek-Haverkamp E; Strijland A; de Jonge A; van den Bergh FA; Tager JM
    Biochim Biophys Acta; 1978 Dec; 527(2):456-64. PubMed ID: 31916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical Fabry's disease occurring in the context of IgA nephropathy.
    Kawamura O; Sakuraba H; Itoh K; Suzuki Y; Doi M; Kuwabara H; Oshima S; Abe S; Warabi H; Yoshizawa N
    Clin Nephrol; 1997 Feb; 47(2):71-5. PubMed ID: 9049452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An atypical variant of Fabry's disease in men with left ventricular hypertrophy.
    Nakao S; Takenaka T; Maeda M; Kodama C; Tanaka A; Tahara M; Yoshida A; Kuriyama M; Hayashibe H; Sakuraba H
    N Engl J Med; 1995 Aug; 333(5):288-93. PubMed ID: 7596372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of ceramide trihexoside in cultured skin fibroblasts from Fabry's patients, carriers and normal controls.
    Kobayashi T; Shinnoh N; Kuroiwa Y
    J Neurol Sci; 1984 Aug; 65(2):169-77. PubMed ID: 6090593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocytosis of lysosomal alpha-galactosidase A by cultured fibroblasts from patients with Fabry disease.
    Mayes JS; Cray EL; Dell VA; Scheerer JB; Sifers RN
    Am J Hum Genet; 1982 Jul; 34(4):602-10. PubMed ID: 6285697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ultrastructural changes in the skin of patients with Fabry's angiokeratoma].
    Aĭvazian AA; Trofimov IB; Seredniakova NI
    Arkh Patol; 1985; 47(7):60-3. PubMed ID: 2996471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.